Health In Tech (NASDAQ:HIT – Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.01), FiscalAI reports. The firm had revenue of $8.06 million during the quarter.
Here are the key takeaways from Health In Tech’s conference call:
- Q2 GAAP revenue fell 13.5% year over year to $8.1 million, while Adjusted EBITDA declined to negative $1.3 million from positive $1.6 million a year ago. Management attributed the revenue decline to policy effective-date shifts during a new carrier onboarding, but operating expenses continued to rise as the company invested in sales, marketing, and technology.
- Management reaffirmed full-year 2026 revenue guidance of $45 million to $50 million, citing $32.3 million of contracted revenue in the first half and $66.3 million of pipeline revenue as of July 31. The company said the contracted revenue is largely locked in but recognized over 12- to 36-month policy terms.
- The distribution network grew 19.9% year over year to 933 brokers, TPAs, and agencies. Health In Tech expects to launch its HitRix large-group marketplace within weeks, giving existing partners access to automated data parsing, simultaneous underwriter submissions, real-time comparisons, and faster closing capabilities.
- The company secured its first employer under its Three-Year Rate Stabilization Program and is pursuing additional large government and municipal organizations. Management also expects an A-rated carrier to be added within roughly 30 days, potentially opening access to larger brokerage firms and increasing future business opportunities.
Health In Tech Trading Down 5.2%
Shares of NASDAQ:HIT traded down $0.06 on Friday, reaching $1.00. 166,732 shares of the company were exchanged, compared to its average volume of 235,339. The company has a 50-day moving average of $1.06 and a 200-day moving average of $1.26. The firm has a market cap of $65.86 million, a price-to-earnings ratio of -50.25 and a beta of 2.82. Health In Tech has a 1-year low of $0.85 and a 1-year high of $4.02.
Institutional Inflows and Outflows
Analyst Upgrades and Downgrades
A number of equities research analysts have weighed in on the company. Craig Hallum started coverage on Health In Tech in a research note on Monday, April 20th. They issued a “buy” rating and a $4.00 price objective for the company. Wall Street Zen cut shares of Health In Tech from a “hold” rating to a “sell” rating in a report on Saturday, April 25th. Maxim Group set a $3.00 price target on shares of Health In Tech in a research note on Friday. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Health In Tech in a research report on Tuesday, June 30th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $3.50.
Get Our Latest Analysis on Health In Tech
About Health In Tech
Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.
See Also
- Five stocks we like better than Health In Tech
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
- CAVA Earnings: The Easiest Comp of the Year Meets a Tough Valuation
Receive News & Ratings for Health In Tech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health In Tech and related companies with MarketBeat.com's FREE daily email newsletter.
